| Groups B and C (19) | Group A (excellent responders) (58) | P value |
---|---|---|---|
Age | Â | Â | 0.624 |
  < 1 year | 11 | 29 |  |
 1–2 years | 4 | 10 |  |
  > 2 years | 4 | 19 |  |
Gender | Â | Â | 0.391 |
 Male | 11 | 27 |  |
 Female | 8 | 31 |  |
Swelling | Â | Â | 0.738 |
 Yes | 13 | 42 |  |
 No | 6 | 16 |  |
 Pain |  |  | 0.827 |
 Yes | 7 | 23 |  |
 No | 12 | 35 |  |
Disfigurement | Â | Â | 0.014 |
 Yes | 15 | 27 |  |
 No | 4 | 31 |  |
Discoloration | Â | Â | 0.04 |
 Yes | 14 | 27 |  |
 No | 5 | 31 |  |
Bleeding | Â | Â | 0.956 |
 Yes | 8 | 24 |  |
 No | 11 | 34 |  |
Limited motion | Â | Â | 0.713 |
 Yes | 2 | 8 |  |
 No | 17 | 50 |  |
Morphological subtypes |  |  |  < 0.001 |
 Macrocystic LMs | 0 | 31 |  |
 Microcystic LMs | 12 | 9 |  |
 Mixed LMs (macrocystic and microcystic) | 7 | 18 |  |
Extent |  |  |  < 0.001 |
 Focal | 9 | 53 |  |
 Diffuse | 10 | 5 |  |